Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers
Trial details
- Registry ID
- NCT04588428
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy VolunteersNCT04588428 | Inovio Pharmaceuticals | Phase 2 | Completed | 2023-01-19Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |